top of page
Image by Warren Umoh

​GENOUS

TM

​SUCCESS STORY

The right drug. The first time. Everytime

On a global scale, cancer brings patients and their families fear, obsession, and even financial exhaustion. Evolutionary mechanisms, sophisticated escape from cancer cell treatments make it one of the most insummissible diseases the world has ever faced. Cancer is like a dark cloud dancing in the sky, obscuring the shining golden sun, and making life lose the joyful scene. In that gloomy picture, it turns out that there are still rays of light for cancer patients.


All thanks to the continuous advances in the field of biomedicine and biomedical technology. New discoveries, new technologies are gradually helping people with cancer feel that it is no longer a nightmare with no way out. Of course, the fight against cancer has never had a pause, but humanity is getting to know it better, and finding more effective "Weapons".


Genomate's artificial intelligence (AI) drug prescription system was born, which has been gradually creating a revolution to promote digital, big data and artificial intelligence in cancer treatment. It helps the implementation of the concept of "Precision Oncology" (Precision Oncology) into practice more fully.


And through the success stories, spreading inspiration of some patients who have applied this solution, we will have more hope for a better future, if unfortunately facing tumors called "CANCER".

-dsc0401-large.jpeg

Long-term survival after metastatic cancer

Kataline is a middle-aged Hungarian woman who was diagnosed with lung cancer with brain metastases in 2012. At the time, her prognosis was just 3 months. Thanks to analysis by Oncompass (a Hungarian company that shares the DDA platform with Genomate),

nut.png

Read more

image.png

Walking Again: A 24-Year-Old Male with Ewing Sarcoma

The 24-year-old young man has faced a tough battle from "Ewing's Sarcoma", a rare form of bone cancer with high malignancy

nut.png

Read more

image.png

New hope for a 43-year-old female patient with HER2 positive breast cancer

A 43-year-old female patient was diagnosed with invasive breast cancer of degree III

nut.png

Read more

11.png

Overcoming adversity: The battle of a young female patient with breast cancer and lung cance

The life of a 33-year-old female patient was turned upside down after she was diagnosed with HER2-positive breast cancer.

nut.png

​Read more

image.png

Successful Clinical Trial Participation for a 62-Year-Old with Cervical Carcinom

A 62-year-old woman was diagnosed with large-cell cervical endocrine neuroma, a highly malignant form of cancer.

nut.png

Read more

image.png

A Game-Changer: A 34-Year-Old Athlete’s Battle with Adenoid Cystic Carcinoma (ACC

The 34-year-old athlete, the diagnosis of ACC in the left eye socket is a shock. This rare and aggressive cancer not only threatens his sports career, but also his life, especially when it has spread to the liver and bones.

image.png

Successful Clinical Trial Participation for a 62-Year-Old with Cervical Carcinom

At 62, this man’s world was turned upside down when he was diagnosed with cholangiocarcinoma, a rare and aggressive cancer of the bile ducts

nut.png
image.png

Long-term stability in a 74-year-old woman with stomach cancer

At the age of 74, the fight against stomach cancer of this female patient is extremely difficult. After undergoing radical surgery and adjuvant chemotherapy, her cancer still metastasized

nut.png

Read more

image.png
nut.png

​Read more

A New Lease on Life: A 62-Year-Old Woman’s Fight Against NSCLC

Diagnosed with non-small cell lung cancer (NSCLC) and brain metastasis 12 years ago, the female patient - then 50 years old - faced a frightening prognosis of only 3 months to live.

image.png

Targeted Therapy Success in a 44-Year-Old Male with Pilocytic Astrocytom

Diagnosed with pilocytic astrocytoma, a slow-growing brain tumor, a 44-year-old man faced a challenging treatment journey. After surgery, he began the Stupp protocol—a standard regimen of chemotherapy and radiation

nut.png

Read more

bottom of page